Cargando…
IV/IT hUC-MSCs Infusion in RRMS and NMO: A 10-Year Follow-Up Study
Background: Stem cell transplantation is emerging as a potential therapeutic strategy in several autoimmune diseases. However, the safety and feasibility of long-term combined intravenous (IV) and intrathecal (IT) administration of hUC-MSCs in relapse remitting multiple sclerosis (RRMS) and neuromye...
Autores principales: | Lu, Zhengjuan, Zhu, Lin, Liu, Zhuo, Wu, Jiayong, Xu, Yun, Zhang, Cun-Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506071/ https://www.ncbi.nlm.nih.gov/pubmed/33013641 http://dx.doi.org/10.3389/fneur.2020.00967 |
Ejemplares similares
-
The high level of IL-1β in the serum of ACLF patients induces increased IL-8 expression in hUC-MSCs and reduces the efficacy of hUC-MSCs in liver failure
por: Wang, Yong-Hong, et al.
Publicado: (2023) -
Efficient expansion and delayed senescence of hUC-MSCs by microcarrier–bioreactor system
por: Wang, Xia, et al.
Publicado: (2023) -
Resveratrol Exerts Dosage-Dependent Effects on the Self-Renewal and Neural Differentiation of hUC-MSCs
por: Wang, Xinxin, et al.
Publicado: (2016) -
Diverse impact of xeno-free conditions on biological and regenerative properties of hUC-MSCs and their extracellular vesicles
por: Bobis-Wozowicz, Sylwia, et al.
Publicado: (2016) -
Corrigendum to: Resveratrol Exerts Dosage-Dependent Effects on the Self-Renewal and Neural Differentiation of hUC-MSCs
por: Wang, Xinxin, et al.
Publicado: (2020)